Guidelines International Network | Guidelines International Network (GIN)

Urotheelcarcinoom van de blaas. National evidence-based guideline

MeSH Terms: Bladder Neoplasms (C04.588.945.947.125); Cancer / Neoplasms (C04); Urologic and Male Genital Diseases (C12); Urogenital Neoplasms (C04.588.945)
English Title Translation: Bladder concer
Publication Scope: management
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2009

MeSH Terms: Breast Neoplasms, breast tumor, breast cancer, breast neoplasm, Diphosphonates, bisphosphonic acid derivative, bisphosphonate, zoledron, ibandron, pamidron, risedron, alendron, neridron, olpadron, clodron, tiludron, etidron, reclast, zometa, aclasta, boniva, aredia, actonel, fosamax, nerixia, bonefos, loron, skelid, didronel, Bone Density Conservation Agents, Endothelin A Receptor Antagonists, denosumab, calcitonin, dasatinib, rilotumumab, cabozantinib, bone-modifying agent, atrasentan, zibotentan, dasatinib, rilotumumab, AMG102, cabozantinib, Prolia, Xgeva, Fortical, Miacalicin, Evista
Guideline Contact: Glenn Fletcher; pebconc@mcmaster.ca
Keywords: breast neoplasms, breast cancer, diphosphonates, bisphosphonate, bone-modifying agent, adjuvant therapy
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-07-14
Date of Last Evidence Search: 2021-01-28
Methods Applied: Evidence-based, Systematic review-based, Externally reviewed, Evidence quality assessmen
Publication Scope: Guidelines; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022

MeSH Terms: Breast Neoplasms (C04.588.180); Biomarkers; Pharmacological (D23.101.137); Neoplasms (C04)
Guideline Contact: guidelines@asco.org
Publication Date: 31-May-19
Publication Scope: treatment
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2019

MeSH Terms: Antineoplastic Agents (D27.505.954.248); Neoplasms (C04); Breast Neoplasms (C04.588.180)
Guideline Contact: guidelines@asco.org
Publication Date: 03-Sep-19
Publication Scope: prevention
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2019

MeSH Terms: Head and Neck Neoplasms (C04.588.443); Laryngeal Neoplasms (C04.588.443.665.481)
Guideline Contact: guidelines@asco.org
Publication Date: 27-Nov-17
Publication Scope: treatment
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2017

MeSH Terms: Respiratory Tract Infections (C08.730); Respiratory Tract Infections (C01.539.739); Pulmonary Ventilation (E01.370.386.700.660); Pulmonary Ventilation (G09.772.650)
Guideline Contact: Chiara Speziale (guidancedocuments@escmid.org)
Publication Scope: treatment
Guideline Publication Status: Published
Languages: English
Authors: ESCMID
Publication Year: 2017

MeSH Terms: Guideline; Sweetening Agents; Sugars; Dietary Sucrose; Obesity; Meta-Analysis as Topic; Systematic Reviews as Topic
Guideline Contact: Jason Montez (montezj@who.int)
English Title Translation: Use of non-sugar sweeteners: WHO guideline
Publication Date: 15-May-23
Countries of Application: International
Guideline Publication Status: Published
Languages: English
Authors: WHO